Glutamic acid decarboxylase autoantibodies and neurological disorders

Neurological Sciences

Volumn 23, Issue 4, 2002, Pages 145-151

  Vianello, M ^a   Tavolato, B ^a   Giometto, B ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Chronic cerebellar ataxia; Epilepsy; GAD autoantibodies; Polyglandular autoimmunity; Stiff person syndrome

Indexed keywords

4 AMINOBUTYRIC ACID; ANESTHETIC AGENT; AUTOANTIBODY; BACLOFEN; BENZODIAZEPINE; GLUTAMATE DECARBOXYLASE ANTIBODY; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; PHENYTOIN; TIZANIDINE;

ADULT; AMINO ACID SYNTHESIS; AUTOIMMUNE DISEASE; CEREBELLAR ATAXIA; CONTROLLED STUDY; ELECTROMYOGRAPHY; ENZYME MECHANISM; EPIDURAL ANESTHESIA; EPILEPSY; EXOCYTOSIS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MYOCLONUS; NERVE ENDING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PLASMAPHERESIS; REVIEW; STIFF MAN SYNDROME;

ANIMALS; AUTOANTIBODIES; BIOLOGICAL MARKERS; CEREBELLAR ATAXIA; CHRONIC DISEASE; EPILEPSY; GLUTAMATE DECARBOXYLASE; HUMANS; NERVOUS SYSTEM DISEASES; POLYENDOCRINOPATHIES, AUTOIMMUNE; STIFF-PERSON SYNDROME;

EID: 0036807537     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100720200055     Document Type: Review

References (65)

1. Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P (1990) Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 322:1555-1560
2. Reetz A, Solimena M, Matteoli M, Folli F, Takei K, De Camilli P (1991) GABA and pancreatic beta-cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvescicles suggest their role in GABA storage and secretion. EMBO J 10(5):1275-1284
3. Erdo SL, Wolff JR (1990) Gamma-aminobutyric acid outside the mammalian brain. J Neurochem 54:363-372
4. Bu DF, Tobin AJ (1994) The exon-intron organization of the genes encoding two human glutamate decarboxylases (GAD 65 and GAD 67) suggests that they derive from a common ancestral GAD. Genomics 21:222-228
5. Erlander MG, Tillkaratne NJ, Feldblum S, Patel N, Tobin AJ (1991) Two genes encode distinct glutamate decarboxylase. Neuron 7:91
6. 2-terminal domain. J Cell Biol 118:309
7. Kim J, Namchuk M, Bugawan T, Fu Q, Jaffe M, Shi Y, Aaustoot H, Turk CW, Erlich H, Lennon V, Baekkeskov S (1994) Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD 65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. Exp Med 180:596-606
8. Solimena M, Folli F, Denis-Dommi S, Comi GC, Pozza G, De Camilli P, Vicari AM (1988) Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med 318:1012-1020
9. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, De Camilli P (1990) Identification of the 64 kD autoantigen in insulin-dependent diabetes as the GABA-synthetizing enzyme glutamic acid decarboxylase. Nature 347:151-156
10. Lenmark A (1996) Glutamic acid decarboxylase - gene to antigen to disease. J Intern Med 240:259-277
11. De Aizpurua HJ, Wilson YM, Harrison LC (1992) Glutamic acid decarboxylase antibodies in preclinical insulin-dependent diabetes. Proc Natl Acad Sci USA 89:9841
12. Hagopian WA, Karlsen AE, Gottsater A, Landin-Olsson M, Grubin CE, Sundkvist G, Petersen, JS, Boel E, Dryberg T, Lenmark A (1993) Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD 65) shows that 64K autoantibody positivity at onset predicts diabetes type. J Clin Invest 91:368
13. Tisch R, Yang X-D, Singer SM, Liblau RS, Fugger L, McDevitt HO (1993) Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366:72-75
14. Bonifacio E, Atkinson M, Eisenbarth G, Serreze D, Kay TWH, Lee-Chan E, Singh B (2001) International workshop on lessons from animal models for human type 1 diabetes. Identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. Diabetes 50:2451-2458
15. Bjork E, Velloso LA, Kampe O, Karlsson FA (1994) GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitope. Diabetes 43:161
16. Daw K, Power AC (1995) Two disinct glutamic acid decarboxylase auto-antibodies specificities in IDDM target difference epitopes. Diabetes 44:216-220
17. Daw K, Ujihara N, Atkinson M, Powers AC (1996) Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recogniton. J Immunol 156:818-825
18. Butler M, Solimena M, Dirkx R, Hayday A, De Camilli P (1993) Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome. J Exp Med 178:2097-2106
19. Genovese S, Bonifacio E, McNally JM, Deam BM, Wagner R, Bosi E, Gale EAM, Bottazzo GF (1992) Distinct cytoplasmatic islet cell antibodies with different risk for type 1 (insulin dependent) diabetes mellitus. Diabetologia 35:385-388
20. Giometto B, Scaravilli T, Nicolao P, An SF, Groves M, Tavolato B, Beckett AJ, Scaravilli F (1996) Detection of paraneoplastic anti-neuronal autoantibodies on paraffin-embedded tissues. Acta Neuropathol 92:435-440
21. Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354
22. Yanagihara T, Hamberger A (1973) A method for separation of Purkinje cell and granular cell-enriched fractions from rabbit cerebellum. Brain Res 59:445-448
23. Schmidli RS, Colman PG, Bonifacio E and Partecipating Laboratories (1995) Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. Diabetes 44:636-640
24. DeAizpurua HJ, Harrison LC, Cram DS (1992) An ELISA for antibodies to recombinant glutamic acid decarboxylase in IDDM. Diabetes 41:1182-1187
25. 125I-glutamic acid decarboxylase in patients with stiff man syndrome. J Neurol Neurosurg Psychiatry 62:395-397
26. Petersen JS, Hejnaes KR, Moody A, Karlsen AE, Marshall MO, Hoier-Madsen M, Boel E, Michelsen BK, Dyrberg T (1994) Detection of GAD 65 antibodies in diabetic and other autoimmune diseases using a simple radioligand assay. Diabetes 43:459-467
27. Grubin CE, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L, Karlsen AE, Boel E, Michelsen B, Lenmark A (1994) A novel radiobinding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37:344-350
28. Meinck HM, Faber L, Morgenthaler N, Seissler J, Maile S, Butler M, Solimena M, De Camilli P, Scherbaum WA (2001) Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases. J Neurol Neurosurg Psychiatry 71(1):100-103
29. Giometto B, Miotto D, Faresin F, Argentiero V, Scaravilli T, Tavolato B (1996) Anti-gabaergic neuron autoantibodies in a patient with stiff-man syndrome and ataxia. J Neurol Sci 143:57-59
30. Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, De Andres C, Maestre J, Fabien N, Vighetto A, Casamitjana R, Thivolet C, Tavolato B, Antoine JC, Trovillas P, Graus F (2001) Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: clinical and immunological study of 14 patients. Arch Neurol 58(2):225-230
31. Honnorat J, Trouillas P, Trivolet C, Aguera M, Belin MF (1995) Autoantibodies to glutamate decarboxylase in a patient with cerebellar cortical atrophy, peripheral neuropathy and slow eye movements. Arch Neurol 52:462-468
32. Saiz A, Arpa J, Sagasta A, Castamitjana R, Zarranz JJ, Tolosa E, Graus F (1997) Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus and polyendocrine autoimmunity. Neurology 49:1026-1030
33. Giometto B, Nicolao P, Macucci M, Tavolato B, Foxon R, Bottazzo GF (1998) Temporal-lobe epilepsy associated with glutamic-acid-decarboxylase autoantibodies. Lancet 352:457
34. Peltola J, Kulmala P, Isojarvi J, Saiz A, Latvala K, Palmio J, Savola K, Knip M, Keranet T, Graus F (2000) Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 55:46-56
35. Nemni R, Braghi S, Natali-Sora MG, Lampasona V, Bonifacio E, Comi G, Canal N (1994) Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy. Ann Neurol 36:665-667
36. Dalakas MC, Fujii M, Li M, McElroy B (2000) The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology 55:1531-1535
37. Kissel JT, Elble RJ (1998) Stiff-person syndrome (stiff opposition to a simple explanation). Neurology 51:11-14
38. Folli F (1998) Stiff-man syndrome, 40 years later. J Neurol Neurosurg Psychiatry 65(5):618
39. Shaw PJ (1999) Stiff-man syndrome and its variants. Lancet 353(9147):86-87
40. Brown P, Marsden CD (1999) The stiff man and stiff man plus syndromes. J Neurol 246:648-652
41. De Camilli P, Thomas A, Cofiell R, Folli F, Lichte B, Piccolo G, Meinck HM, Austom M, Fassetta G, Bottazzo G et al (1993) The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of stiff-man syndrome with breast cancer. J Exp Med 178:2219-2223
42. Butler MH, Hayashi A, Ohkoshi N, Villmann C, Becker CM, Feng G, De Camilli P, Solimena M (2000) Autoimmune to gephyrin in stiff-man syndrome. Neuron 26:307-312
43. Meinck HM, Ricker K, Hulser PJ, Solimena M (1995) Stiff-man syndrome: neurophysiological findings in eight patients. J Neurol 242:134-142
44. Howard FM (1963) A new and effective drug in the treatment of the stiff-man syndrome: preliminary report. Proc Staff Meet Mayo Clin 38:203-212
45. Gordon EE, Januszko DM, Kaufman L (1967) A critical survey of stiff-man syndrome. Ann J Med 42:582-599
46. Floeter MK, Valls-Solè J, Toro C, Jacobowitz D, Hallett M (1998) Physiologic studies of spinal circuits in patient with stiff-person syndrome. Neurology 51:85-93
47. 65 antibodies. Neurology 57:780-784
48. Vicari AM, Folli F, Pozza G, Comi GC, Comola M, Canal N, Besana C, Borri A, Tresoldi M, Solimena M (1989) Plasmapheresis in the treatment of stiff-man syndrome. N Engl J Med 320:1499
49. Amato AA, Cornman EW, Kissel JT (1994) Treatment of stiff-man syndrome with intravenous immunoglobulin. Neurology 44:1652-1654
50. Dalakas MC, Fujii M, Li M, Lutfi B, Kyhos J, McElroy B (2001) High-dose intravenous immune globulin for stiff-person syndrome. N Engl J Med 345:1870-1876
51. Hao W, Davis C, Hrsch IB, Eng LJ, Daniels T, Walsh D, Lenmark A (1999) Plasmapheresis and immunosuppression in stiff-man syndrome with type 1 diabetes: a 2-year study. J Neurol 246(8):731-735
52. Piccolo G, Cosi V, Zandrini C, Moglia A (1988) Steroid-responsive and dependent stiff-man syndrome: a clinical and electrophysiological study of two cases. Ital J Neurol Sci 9:559-566
53. Abele M, Weller M, Mescheriakov S, Burk K, Dichgans J, Klockgether T (1999) Cerebellar ataxia with glutamic acid decarboxylase autoantibodies. Neurology 52(4):857-859
54. Betterle C, Greggio A, Volpato M (1997) Autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab 83:1049-1055
55. Betterle C, Presotto F, Pedini B, Greggio NA, Accolla R, Zanchetta. R (1997) Generalità sulle malattie autoimmuni. In: Betterle C (ed) Gli autoanticorpi. Manuale-atlante a colori di diagnostica. Piccin, Padua, pp 223-236
56. Betterle C, Volpato M, Greggio AN, Presotto F (1996) Type 2 polyglandular autoimmune disease (Schmidt's syndrome). J Pedriatic Endocrinol Metab 9[Suppl 1]:113-123
57. Marchiori GC, Vaglia A, Vianello M, Bardin PG, Giometto B (2001) Encephalitis associated with glutamic acid decarboxylase autoantibodies. Neurology 56(6):814
58. Ishida K, Mitoma H, Song S-Y, Uchihara T, Inaba A, Eguchi S, Kobayashi T, Mizusawa H (1999) Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase. Ann Neurol 46:263-267
59. Mitoma H, Song S-Y, Ishida K, Yamakuni T, Kobayashi T, Mizusawa H (2000) Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase. J Neurol Sci 175:40-44
60. Takenoshita H, Shizuka-lkeda M, Mitoma H, Song S, Harigaya Y, Igeta Y, Yaguchi M, Ishida K, Shoji M, Tanaka M, Mizusawa H, Okamoto K (2001) Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia. J Neurol Neurosurg Psychiatry 70(3):386-389
61. Dinkel K, Meinck H-M, Jury KM, Karges W, Richter W (1998) Inhibition of γ-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann Neurol 44:194-201
62. Alarcon-Segovia D, Ruid-Arguelles A, Llorente L (1996) Broken dogma: penetration of autoantibodies into living cells. Immunol Today 17:163-164
63. Wenthold RJ, Skaggs KK, Reale RR (1984) Retrograde axonal transport of antibodies to synaptic membrane components. Brain Res 304:162-165
64. Madaio MP, Fabbi M, Tiso M (1996) Spontaneously produced anti-DNA/DNase I autoantibodies modulate nuclear apoptosis in living cells. Eur J Immunol 26:3035-3041
65. Lohmann T, Hawa M, Leslie RDG, Lane R, Picard J, Londei M (2000) Immune reactivity to glutamic acid decarboxylase 65 in stiff-man syndrome and type 1 diabetes mellitus. Lancet 356(9223):31-35